en

PRODUCT DETAIL

LIVTENCITY 200 mg filmom obalené tablety

Code 2345E
MA number EU/1/22/1672/002
Product Form: tbl flm 56x200 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
MAH, country: Takeda Pharmaceuticals International AG Ireland Branch, Ireland
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX10 Maribavir
Shelf life: 30
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 09.11.2022
Validity: 09.11.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.11.2022
eu-flag.png sk-flag.png